|
Regulation
Citations 1-10 of 214 total displayed.
|
Most recent content
(10 Nov 2009):
|
- News
China’s counterfeit medicine trade booming
- Katie Lewis
Can. Med. Assoc. J. 2009; 181: E237-238E.
[Full text]
[PDF]
|
Past content
(since Jul 1999):
|
- News
Enzyme therapy for Fabry patients in jeopardy
- Ann Silversides
Can. Med. Assoc. J. 2009; 181: E120.
[Full text]
[PDF]
- News
Fabry trial set to answer "political problem"
- Ann Silversides
Can. Med. Assoc. J. 2009; 181: 365-366.
[Full text]
[PDF]
- News
Charter challenge of ban on direct-to-consumer advertising to be heard by Ontario court in mid-June
- Ann Silversides
Can. Med. Assoc. J. 2009; 181: E5-6E.
[Full text]
[PDF]
- News
Clinical trials: the balance between protecting participants and promoting drug and product development
- Miriam Shuchman
Can. Med. Assoc. J. 2009; 180: 603-606.
[Full text]
[PDF]
- News
Clinical trial participation poses ethical, practical issues
- Ann Silversides
Can. Med. Assoc. J. 2009; 180: 500-502.
[Full text]
[PDF]
- News
Clinical trials: chasing recruits
- Ann Silversides
Can. Med. Assoc. J. 2009; 180: 375-378.
[Full text]
[PDF]
- News
Antismoking drug still recommended to Canadians despite side effects and US advisory
- Roger Collier
Can. Med. Assoc. J. 2009; 180: 381.
[Full text]
[PDF]
- News
Clinical trials: the muddled Canadian landscape
- Ann Silversides
Can. Med. Assoc. J. 2009; 180: 20-22.
[Full text]
[PDF]
- News
Clinical trials regulation — how Canada compares
- Miriam Shuchman, MD
Can. Med. Assoc. J. 2008; 179: 635-638.
[Full text]
[PDF]
|
|
